Aoxin Q & M Dental Group (SGX:1D4) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1D4 Aoxin Q & M Dental Group Ltd SGX:1D4
55 GF Score
Price S$0.24
GF Value S$0.05
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Aoxin Q & M Dental Group FFO?

FFO (Funds from operations) only applies to REITs.

SGX:1D4
55GF Score
Aoxin Q & M Dental Group Ltd SGX:1D4
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aoxin Q & M Dental Group (SGX:1D4) Overvalued in 2026?

Based on GuruFocus' analysis, Aoxin Q & M Dental Group stock appears to be overvalued. The current stock price of S$0.24 is trading 380% above its estimated GF Value™ of S$0.05. GuruFocus considers Aoxin Q & M Dental Group to be Significantly Overvalued.

Key valuation signals for SGX:1D4:

  • FFO:
  • GF Value™: S$0.05 vs. price of S$0.24 (380% above fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the SGX:1D4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aoxin Q & M Dental Group Business Description

Address 9 Raffles Place, No. 26-01, Republic Plaza, Singapore, SGP, 048619
Aoxin Q & M Dental Group Ltd, along with its subsidiaries, offers private dental services, dental equipment, and supplies. The various dental care services offered by the Group include Stomatology and general dentistry, Endodontics, Orthodontics, Periodontics, Dental implantology, and many more. Its dental equipment and supplies portfolio includes dental chairs, ultrasound scanners, dental instruments, materials, and consumables for dental hospitals, clinics, distributors, and laboratories. The Group's reportable operating segments are: Primary healthcare, which generates the maximum revenue, Distribution of dental equipment and supplies, and Laboratory services. Geographically, it generates maximum revenue from the People's Republic of China (PRC) and the rest from Singapore.
55GF Score

Get the complete analysis for SGX:1D4

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.24
Price
S$0.05
GF Value